SCHEDULE: FMR LLC & Abigail Johnson Report Glaukos Stake
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 4.5% beneficial ownership stake in Glaukos Corp's common stock.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 3 to Schedule 13G regarding their beneficial ownership in Glaukos Corp.
- As of July 31, 2025, FMR LLC and Abigail P. Johnson collectively beneficially own 2,561,428.45 shares of Glaukos Corp's common stock.
- This aggregate amount represents 4.5% of the total outstanding common stock of Glaukos Corp.
- FMR LLC holds sole voting power over 2,508,353.41 shares and sole dispositive power over 2,561,428.45 shares.
- Abigail P. Johnson holds sole dispositive power over 2,561,428.45 shares, with no sole or shared voting power reported.
- The filing confirms that the securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Glaukos Corp.
Sentiment
Score: 5
Explanation: This filing is a routine disclosure of beneficial ownership, indicating a passive investment stake. It does not contain information that would typically influence sentiment positively or negatively regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Structure Disclosure | Abigail P. Johnson is a Director, Chairman, and CEO of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners of Series B voting common shares of FMR LLC (49% voting power). They have a shareholders' voting agreement to vote Series B shares in accordance with the majority vote, potentially forming a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | NA | This disclosure pertains to the internal governance and control structure of the reporting entity (FMR LLC) and its affiliates, not the issuer (Glaukos Corp). It clarifies the ultimate control over the reported beneficial ownership. |
Stakeholder Impact
- Shareholders of Glaukos Corp: Provides transparency regarding a significant institutional investor's passive stake, confirming no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2023-05-23 | Effective date of Power of Attorney for Richard Bourgelas to sign on behalf of FMR LLC and Abigail P. Johnson. |
| 2025-07-31 | Date of event which requires filing of this statement (measurement date for beneficial ownership). |
| 2025-08-06 | Date of filing of this Schedule 13G Amendment No. 3. |
Keywords
Glaukos Corp, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.